Production stage Sample Clauses

Production stage. The production stage comprises the manufacture of the raw materials, the transport of the raw materials to each partner’s facilities and the production and assembly of all the individual components into the final product. Although the information for this stage has been largely provided by demonstration sites, when needed, some assumptions needed to be made to cover significant data gaps.
Sample 1
AutoNDA by SimpleDocs
Production stage. Upon receipt and final approval of samples submitted to Startale, AKA shall provide a quote for production and packaging of the Products. Startale shall reserve the right to reject any quotes and shall not be under any obligation to continue further production.
Sample 1
Production stage. The production operations team assumes ownership for the project with emphasis on meeting customer production requirements, driving continuous improvement and identifying/implementing cost reductions. DECISION POINT: The Recipient is not authorized to proceed with activity beyond Phase I without the specific written approval of the DOE Contracting Officer. The continuation of the project will be based upon the selection of the Phase II site and the successful completion of the Phase II site NEPA. PHASE II: Creation of Application Specific Electric Drive Motors and Inverters and Expand Production Capacity.
Sample 1
Production stage. The production operations team assumes ownership for the project with emphasis on meeting customer production requirements, driving continuous improvement and identifying/implementing cost reductions.
Sample 1

Related to Production stage

  • STAGE The aggrieved may within twenty-one (21) calendar days after an occurrence, or in the case of disciplinary action within twenty-one (21) calendar days after same has been brought to the attention of the reduce the grievance to writing and accompanied by representatives of the Grievance Committee, take the matter up with the Fire Chief. The Fire Chief shall, within seven (7) calendar days, arrange a meeting place and time to discuss and attempt to settle the grievance. The Corporation will be represented at this stage of the grievance procedure by the Fire Chief and the Director of Human Resources. Grievancesthat are not settled within seven (7)calendar days of the meeting may be referred to Stage provided that not more than seven (7) calendar days have elapsed since the meeting at Stage STAGE2 The aggrieved shall reconsider the grievance and the Fire Chief's response at Stage and decide within five (5) calendar days whether to proceed with the grievance. If the aggrieved wishes to proceed, the Assistant City Manager of Emergency and Corporate Services, the Fire Chief, and the Director of Human Resources will meet with the aggrieved accompanied by representatives of the Grievance Committee within seven (7) calendar days of notification by the aggrieved Failing settlement at this stage, Stage of the grievance procedure may be invoked provided that no more than seven (7) calendar days have elapsed since the hearing at Stage STAGE The aggrieved accompanied by representatives of the Grievance Committee, may then take the written grievance to a committee of Council members. In the case of discharge, the grievance shall be heard by the entire Council. Failing settlement at this stage within fourteen (14) calendar days, then the grievance may be referredto Arbitration, as provided under the "Fire Protectionand Prevention Act Part as amended, provided that not more than thirty

  • Trials The Ship shall run the following test and trials:

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Re-Study If Re-Study of the Interconnection Facilities Study is required due to a higher queued project dropping out of the queue or a modification of a higher queued project pursuant to Section 4.4, Transmission Provider shall so notify Interconnection Customer in writing. Such Re-Study shall take no longer than sixty (60) Calendar Days from the date of notice. Any cost of Re-Study shall be borne by the Interconnection Customer being re-studied.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Development Work Do, or cause to be done, such development and other work as may be reasonably necessary to protect from diminution and production capacity of the Mortgaged Property and each producing well thereon.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Transporting Students Teachers shall not be required to transport a student in a private vehicle on behalf of the school.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

Time is Money Join Law Insider Premium to draft better contracts faster.